Microbial Biofilms in Healthcare: Formation, Prevention and Treatment
Biofilms are ubiquitous and their presence in industry can lead to production losses. However, nowhere do biofilms impact human health and welfare as much as those that are found contaminating the healthcare environment, surgical instruments, equipment, and medical implantable devices. Approximately...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03627naaaa2200841uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_53392 | ||
| 005 | 20210211 | ||
| 020 | |a books978-3-03928-411-5 | ||
| 020 | |a 9783039284115 | ||
| 020 | |a 9783039284108 | ||
| 024 | 7 | |a 10.3390/books978-3-03928-411-5 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Vickery, Karen |4 auth | |
| 245 | 1 | 0 | |a Microbial Biofilms in Healthcare: Formation, Prevention and Treatment |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (166 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Biofilms are ubiquitous and their presence in industry can lead to production losses. However, nowhere do biofilms impact human health and welfare as much as those that are found contaminating the healthcare environment, surgical instruments, equipment, and medical implantable devices. Approximately 70% of healthcare-associated infections are due to biofilm formation, resulting in increased patient morbidity and mortality. Biofilms formed on medical implants are recalcitrant to antibiotic treatment, which leaves implant removal as the principal treatment option. In this book, we investigate the role of biofilms in breast and dental implant disease and cancer. We include in vitro models for investigating treatment of chronic wounds and disinfectant action against Candida sp. Also included are papers on the most recent strategies for treating biofilm infection ranging from antibiotics incorporated into bone void fillers to antimicrobial peptides and quorum sensing. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a antibiotic | ||
| 653 | |a biofilm inhibition | ||
| 653 | |a release | ||
| 653 | |a chlorine dioxide | ||
| 653 | |a biofilm formation | ||
| 653 | |a oral bacteria | ||
| 653 | |a breast implants | ||
| 653 | |a instillation therapy | ||
| 653 | |a biofilm | ||
| 653 | |a nosocomial pathogens | ||
| 653 | |a breast implant | ||
| 653 | |a biomaterials | ||
| 653 | |a bacterial biofilms | ||
| 653 | |a chronic wounds | ||
| 653 | |a Staphylococcus aureus | ||
| 653 | |a quorum sensing | ||
| 653 | |a periodontitis | ||
| 653 | |a sodium hypochlorite | ||
| 653 | |a biofilms | ||
| 653 | |a antibiotics | ||
| 653 | |a transferability | ||
| 653 | |a Candida auris | ||
| 653 | |a disinfection | ||
| 653 | |a sodium dichloroisocyanurate | ||
| 653 | |a zone of inhibition | ||
| 653 | |a healthcare | ||
| 653 | |a textured: capsular contracture | ||
| 653 | |a topical negative pressure wound therapy | ||
| 653 | |a Pseudomonas aeruginosa | ||
| 653 | |a multidrug efflux pumps | ||
| 653 | |a anaplastic large cell lymphoma | ||
| 653 | |a calcium sulfate | ||
| 653 | |a peri-implantitis | ||
| 653 | |a BIA-ALCL | ||
| 653 | |a anti-adhesion | ||
| 653 | |a dry surface biofilms | ||
| 653 | |a calcium sulphate | ||
| 653 | |a regrowth | ||
| 653 | |a mechanism of action | ||
| 653 | |a anti-biofilms | ||
| 653 | |a peracetic acid | ||
| 653 | |a bacterial phenotypes | ||
| 653 | |a anti-biofilm strategies | ||
| 653 | |a medical devices | ||
| 653 | |a in vitro | ||
| 653 | |a dry-biofilm | ||
| 653 | |a commensal bacteria | ||
| 653 | |a dispersion | ||
| 653 | |a Klebsiella pneumoniae | ||
| 653 | |a antimicrobial peptides | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2095 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/53392 |7 0 |z DOAB: description of the publication |